Aeglea BioTherapeutics (AGLE) announced the appointment of Scott Burrows, as Chief Financial Officer, CFO, and Heidy Abreu King-Jones as Chief Legal Officer, CLO, and Corporate Secretary. Both will report to Cameron Turtle, Chief Operating Officer of Aeglea, and join the Company’s leadership team. Aeglea also announced that Jonathan Alspaugh, Aeglea’s current President and Chief Financial Officer, is expected to transition into a strategic advisory consulting role through December 31, 2023. Burrows most recently served as the Chief Financial Officer of Arcutis Biotherapeutics (ARQT) where he helped lead Arcutis through a successful initial public offering, several further equity and debt financings, and the transition to a fully integrated commercial-stage company. King-Jones most recently served as the Chief Legal Officer and Corporate Secretary at Provention Bio.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AGLE:
- Aeglea BioTherapeutics Reports Second Quarter 2023 Financial Results
- Aeglea BioTherapeutics reports Q2 EPS ($2.27) vs. (27c) last year
- Aeglea BioTherapeutics files to sell 1.1M shares of common stock for holders
- AGLE Upcoming Earnings Report: What to Expect?
- Aeglea BioTherapeutics initiated with a Buy at Stifel
